The FDA has recently issued a recall for 13 different types of Mylan's EpiPens and EpiPen Jr. auto-injector projects. The FDA website has reported that these EpiPens may contain defective parts. This product is manufactured by Meridian Medical Technologies and distributed by Mylan Specialty.
Although few have been found to be defective, the FDA is recalling 13 types of EpiPens distributed in the U.S. from Dec. 17, 2015, to July 1, 2016.
In a news release, the FDA stated: "This recall is due to the potential that these devices may contain a defective part that may result in the devices' failure to activate."
Mylan was criticized for increasing the price of EpiPens. A two-pack of EpiPens in 2009 was only $100 and by 2016 price had skyrocketed to $609.
In October, the company agreed to pay the U.S. $465 million after they overcharged their EpiPen to the Medicare system. According to Pix 11, Mylan now offers $300 savings cards for patients who have to pay the full price of EpiPens. They have also started creating a generic spinoff product that will be offered at a lower price.
To see the list of EpiPens that have been recalled or to report your EpiPen as defective, click here.